NY Times explores Chinese peptides as new tech-world biohacking trend

Posted by earlysarah in Research & News - 2 points, 0 comments.

https://www.peptidejournal.org/news/chinese-peptides-gray-market-biohacking

The New York Times ran a piece this week about tech workers in their 20s and 30s using cheap peptides sourced directly from China. The article describes backyard gatherings where founders and AI researchers discuss buying compounds like semaglutide and other research chemicals without prescriptions. It frames this as the latest wave in Silicon Valley's biohacking scene, driven by easy online access and low cost.

I found the article striking because it puts a human face on something I've seen discussed cautiously in research circles. What seemed overhyped was the framing of this as harmless optimization, the reality check came when the piece noted customs data and regulatory gaps. What felt left out was any real discussion of safety data; the article treated it as a curiosity rather than a public health concern. How does this square with what people here are actually doing versus what the headline suggests?

Community discussion - research and educational context only. Not medical advice.